Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Breast Neoplasms × Injections × Clear all

Phase

Status

Sponsor Class

INDUSTRY 29 OTHER 18 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Neuroendocrine Tumors 1 Intestinal Neoplasms 1 Hematopoietic Recovery 1 HER2 Low Breast Carcinoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Adenoma, Islet Cell 1

Interventions

Tamoxifen 9 Docetaxel 8 Trastuzumab 7 Paclitaxel 6 Letrozole 6 Gemcitabine 6 Exercise 6 Indocyanine Green 5 Cyclophosphamide 5 Control Groups 5 Carboplatin 5 pertuzumab 4 exemestane 4 Doxorubicin 4 Capecitabine 4 Anastrozole 4 dalpiciclib 3 Vinorelbine 3 Standard of Care 3 Radiotherapy 3 Radiation 3 Mammography 3 Cisplatin 3 pyrotinib 2 ferumoxides 2 Zoledronic Acid 2 Tablets 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03024580 2019-08-15

MEGA

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡